Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: Report of two cases

被引:0
作者
Lin, TK [1 ]
Hsu, MML [1 ]
Lee, JYY [1 ]
机构
[1] Natl Cheng Kung Univ Hosp, Dept Dermatol, Tainan, Taiwan
关键词
widespread bullous fixed drug eruption; toxic epidermal necrolysis; Stevens-Johnson syndrome; diclofenac; naproxen; ketoprofen;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Widespread bullous fixed drug eruption (FDE) is the most severe form of FDE and may be mistaken clinically for Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN). We report two cases of generalized bullous drug eruption with extensive epidermal necrosis and detachment mimicking SJS/TEN overlap and TEN, respectively. The first patient, a 78-year-old man, developed SJS/TEN-like eruption with widespread dusky red patches and denuded areas shortly after taking multiple nonsteroidal antiinflammatory drugs (NSAIDs). Histopathology showed vacuolar interface dermatitis with numerous necrotic keratinocytes and a superficial and deep perivascular infiltrate containing lymphocytes, eosinophils, neutrophils and melanophages. These findings are consistent with FDE. The second patient, a 61-year-old woman, had three episodes of near-total body epidermal detachment shortly after taking NSAIDs. TEN was diagnosed clinically in all three episodes without pathologic confirmation. FDE was suspected due to lack of involvement of two mucosal sites and uneventful recovery. These cases highlight the importance of considering severe bullous FDE in the differential diagnosis of SJS and TEN, and the necessity of skin biopsy in such cases.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 50 条
[31]   Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis [J].
Abe, Riichiro .
JOURNAL OF DERMATOLOGY, 2015, 42 (01) :42-48
[32]   Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Spectrum for the Rheumatologist [J].
Parida, Jyoti Ranjan ;
Tripathy, Saumya Ranjan .
INDIAN JOURNAL OF RHEUMATOLOGY, 2019, 14 :S67-S75
[33]   Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis [J].
Marianne Lerch ;
Carlo Mainetti ;
Benedetta Terziroli Beretta-Piccoli ;
Thomas Harr .
Clinical Reviews in Allergy & Immunology, 2018, 54 :147-176
[34]   Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum [J].
Knowles, Sandra ;
Shear, Neil H. .
DERMATOLOGIC THERAPY, 2009, 22 (05) :441-451
[35]   Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases [J].
Lee, H-Y ;
Tey, H-L ;
Pang, S-M ;
Thirumoorthy, T. .
LUPUS, 2011, 20 (06) :647-652
[36]   Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Historical considerations [J].
Roujeau, Jean-Claude .
DERMATOLOGICA SINICA, 2013, 31 (04) :169-174
[37]   Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report [J].
Zuo, Wei ;
Wen, Li-Ping ;
Li, Jun ;
Mei, Dan ;
Fu, Qiang ;
Zhang, Bo .
MEDICINE, 2019, 98 (19)
[38]   Evidence of Neuropsychological Dysfunction in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Case Report [J].
Henry, George K. .
CLINICAL NEUROPSYCHOLOGIST, 2014, 28 (05) :841-850
[39]   Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome [J].
Ameen, Kaderthambi Hajamohideen Nooru ;
Pinninti, Rakesh ;
Jami, Swathi .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (01) :69-71
[40]   Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis [J].
Cheng, Lin .
FRONTIERS IN PHARMACOLOGY, 2021, 12